261 related articles for article (PubMed ID: 31214024)
1. A Model for Apoptotic-Cell-Mediated Adaptive Immune Evasion
Yakoub AM; Schülke S
Front Pharmacol; 2019; 10():562. PubMed ID: 31214024
[TBL] [Abstract][Full Text] [Related]
2. Autoantigen-Harboring Apoptotic Cells Hijack the Coinhibitory Pathway of T Cell Activation.
Yakoub AM; Schulz R; Seiffert M; Sadek M
Sci Rep; 2018 Jul; 8(1):10533. PubMed ID: 30002409
[TBL] [Abstract][Full Text] [Related]
3. The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins.
van Wijk F; Nierkens S; de Jong W; Wehrens EJ; Boon L; van Kooten P; Knippels LM; Pieters R
J Immunol; 2007 Jun; 178(11):6894-900. PubMed ID: 17513738
[TBL] [Abstract][Full Text] [Related]
4. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
Salomon B; Bluestone JA
Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
[TBL] [Abstract][Full Text] [Related]
5. Differential requirement for CD28/CTLA-4-CD80/CD86 interactions in drug-induced type 1 and type 2 immune responses to trinitrophenyl-ovalbumin.
Nierkens S; Aalbers M; Bol M; Bleumink R; van Kooten P; Boon L; Pieters R
J Immunol; 2005 Sep; 175(6):3707-14. PubMed ID: 16148116
[TBL] [Abstract][Full Text] [Related]
6. Challenges and opportunities in targeting the CD28/CTLA-4 pathway in transplantation and autoimmunity.
Crepeau RL; Ford ML
Expert Opin Biol Ther; 2017 Aug; 17(8):1001-1012. PubMed ID: 28525959
[TBL] [Abstract][Full Text] [Related]
7. [Manipulation of costimulatory pathways in autoimmune disease].
Kaneko H; Nakajima A; Azuma M
Nihon Rinsho; 1997 Jun; 55(6):1531-6. PubMed ID: 9200944
[TBL] [Abstract][Full Text] [Related]
8. Molecular and Cellular Functions of CTLA-4.
Van Coillie S; Wiernicki B; Xu J
Adv Exp Med Biol; 2020; 1248():7-32. PubMed ID: 32185705
[TBL] [Abstract][Full Text] [Related]
9. Soluble CTLA-4 in autoimmune thyroid diseases: relationship with clinical status and possible role in the immune response dysregulation.
Saverino D; Brizzolara R; Simone R; Chiappori A; Milintenda-Floriani F; Pesce G; Bagnasco M
Clin Immunol; 2007 May; 123(2):190-8. PubMed ID: 17321799
[TBL] [Abstract][Full Text] [Related]
10. [Costimulatory molecules in autoimmunity: role of CD28/CTLA4-CD80/CD86].
Nakajima A; Azuma M
Nihon Rinsho; 1997 Jun; 55(6):1419-24. PubMed ID: 9200926
[TBL] [Abstract][Full Text] [Related]
11. Coinhibitory T-cell signaling in islet allograft rejection and tolerance.
Truong W; Hancock WW; Anderson CC; Merani S; Shapiro AM
Cell Transplant; 2006; 15(2):105-19. PubMed ID: 16719045
[TBL] [Abstract][Full Text] [Related]
12. Costimulation Blockade in Autoimmunity and Transplantation: The CD28 Pathway.
Adams AB; Ford ML; Larsen CP
J Immunol; 2016 Sep; 197(6):2045-50. PubMed ID: 27591335
[TBL] [Abstract][Full Text] [Related]
13. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
14. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.
Carreno BM; Collins M
Annu Rev Immunol; 2002; 20():29-53. PubMed ID: 11861596
[TBL] [Abstract][Full Text] [Related]
15. Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis.
Bonelli M; Göschl L; Blüml S; Karonitsch T; Hirahara K; Ferner E; Steiner CW; Steiner G; Smolen JS; Scheinecker C
Rheumatology (Oxford); 2016 Apr; 55(4):710-20. PubMed ID: 26672908
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD80 on cultured neonatal mice cardiomyocytes and attenuation of cytotoxic T lymphocyte-mediated lysis.
Nengwen K; Su A; Youping L
Transplant Proc; 2014; 46(1):266-70. PubMed ID: 24507064
[TBL] [Abstract][Full Text] [Related]
17. T cell costimulation molecules CD80/86 inhibit osteoclast differentiation by inducing the IDO/tryptophan pathway.
Bozec A; Zaiss MM; Kagwiria R; Voll R; Rauh M; Chen Z; Mueller-Schmucker S; Kroczek RA; Heinzerling L; Moser M; Mellor AL; David JP; Schett G
Sci Transl Med; 2014 May; 6(235):235ra60. PubMed ID: 24807557
[TBL] [Abstract][Full Text] [Related]
18. Targeting T cell costimulation in autoimmune disease.
Stuart RW; Racke MK
Expert Opin Ther Targets; 2002 Jun; 6(3):275-89. PubMed ID: 12223069
[TBL] [Abstract][Full Text] [Related]
19. Selective Costimulation Blockade With Antagonist Anti-CD28 Therapeutics in Transplantation.
Vanhove B; Poirier N; Soulillou JP; Blancho G
Transplantation; 2019 Sep; 103(9):1783-1789. PubMed ID: 30951014
[TBL] [Abstract][Full Text] [Related]
20. Cell death recognition model for the immune system.
Sun E
Med Hypotheses; 2008; 70(3):585-96. PubMed ID: 17681705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
